Loading...
•
Dec 31, 2022
Cross Country Healthcare Q4 2022 Earnings Report
Announced financial results for the fourth quarter and full year ended December 31, 2022.
Key Takeaways
Cross Country Healthcare reported Q4 2022 consolidated revenue of $628.2 million, a slight decrease year-over-year and quarter-over-quarter. Diluted EPS was $1.05, compared to $2.07 in the prior year and $0.93 in the prior quarter. Net income attributable to common stockholders was $38.8 million, down from $77.6 million in the prior year and up from $34.8 million in the prior quarter.
Fourth quarter consolidated revenue was $628.2 million, a slight decrease from the prior year and prior quarter.
Consolidated gross profit margin was 22.1%, down 90 basis points year-over-year and 50 basis points sequentially.
Diluted earnings per share (EPS) was $1.05 compared to $2.07 in the prior year and $0.93 in the prior quarter.
Adjusted EPS was $1.09 compared to $1.40 in the prior year and $1.07 in the prior quarter.
Revenue by Segment
Forward Guidance
The guidance below applies only to management’s expectations for the first quarter of 2023. We reaffirm our 2023 annual targets of a minimum $2.2 billion in revenue and $200 million in Adjusted EBITDA.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...